CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...
Improvements in the PSA screening process make it worth another look.
An analysis of United States data reveals a broad shift away from overtreatment of low-risk prostate cancer. The analysis ...
UCL trial of 6,000 prostate cancer patients found the Decipher genetic test indicates which tumours are going to spread amid ...
Thousands of men with high-risk prostate cancer could soon live longer, thanks to a test that helps doctors identify which ...
Newswise — PLYMOUTH MEETING, PA [April 28, 2026] — The National Comprehensive Cancer Network ® (NCCN ®)—an alliance of leading cancer centers—has published a new book explaining the latest evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results